Vesuvius plc
30 April 2020
Notification of Change in Director's Details
Vesuvius plc announces that Douglas Hurt, Senior Independent Director and Chair of the Audit Committee of the Company, has been appointed as an independent non-executive director of Hikma Pharmaceuticals PLC effective 1 May 2020.
This notification is made in accordance with paragraph 9.6.14R of the Listing Rules.
For further information please contact:
Henry Knowles, General Counsel and Company Secretary |
+44 (0) 20 7822 0000 |
Pamela Antay, Head of Investor Relations |
+44 (0) 7827 802277 |
Vesuvius plc, 165 Fleet Street, London EC4A 2AE
Registered in England and Wales No. 8217766
LEI: 213800ORZ521W585SY02
About Vesuvius plc
Vesuvius is a global leader in molten metal flow engineering and technology, serving process industries operating in challenging high-temperature conditions.
We develop innovative and customised solutions, often used in extremely demanding industrial environments, which enable our customers to improve their manufacturing processes, enhance product quality and reduce energy consumption. These include flow control solutions, advanced refractories and other consumable products and increasingly, related technical services including data capture.
We have a worldwide presence. We serve our customers through a network of low-cost manufacturing plants located close to their own facilities, and embed our industry experts within their operations, who are all supported by our global technology centres.
Our core competitive strengths are our market and technology leadership, strong customer relationships, well established presence in developing markets and our global reach, all of which facilitate the expansion of our addressable markets.
Our ultimate goal is to create value for our customers, and to deliver sustainable, profitable growth for our shareholders giving a superior return on their investment whilst providing each of our employees with a safe workplace where he or she is recognised, developed and properly rewarded.